MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
1060.18%
Quick Ratio
1060.18%
Debt to Asset Ratio
9.14%
Unit: Dollar
Assets Breakdown
    • Cash
    • Property & equipment, net
    • Short-term investments
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Non-controlling interest
    • Others
Balance Sheets
2026-05-31
2026-02-28
2025-11-30
2025-08-31
Cash
3,475,003
5,128,141
4,281,233
1,802,123
Short-term investments
142,103
141,266
143,267
143,267
Marketable securities
0
0
0
22,093
Accounts receivable
48,998
42,029
88,044
368,358
Prepaid expenses and other current assets
398,765
458,846
850,585
1,132,504
Total current assets
4,064,869
5,770,282
5,363,129
3,468,345
Long-term receivables
64,014
64,014
64,013
64,013
Right of use assets
84,415
92,018
99,485
106,816
Intellectual property, net
339,016
318,058
308,060
307,818
Property & equipment, net
229,017
242,931
216,120
228,129
Total non-current assets
716,462
717,021
687,678
706,776
Total assets
4,781,331
6,487,303
6,050,807
4,175,121
Accounts payable and accrued liabilities
350,377
182,611
1,425,433
1,463,046
Deferred revenue
-
-
-
0
Lease liability, current
33,035
32,060
31,101
30,417
Total current liabilities
383,412
214,671
1,456,534
1,493,463
Lease liabilities - non-current
53,679
62,326
70,819
78,903
Total liabilities
437,091
276,997
1,527,353
1,572,366
Authorized 220,000,000 common voting shares with a par value of 0.001 per share common shares issued and outstanding 24,787,446 and 19,559,179 at may 31, 2026 and august 31, 2025, respectively
24,788
24,888
22,226
19,559
Additional paid-in capital
73,256,696
73,138,652
70,022,365
66,501,086
Accumulated deficit
-68,496,801
-66,505,599
-65,055,620
-63,460,613
Accumulated other comprehensive loss
-46,473
-55,444
-76,079
-70,335
Equity attributable to shareholders of lexaria
4,738,210
6,602,497
4,912,892
2,989,697
Non-controlling interest
-393,970
-392,191
-389,438
-386,942
Total stockholders' equity
4,344,240
6,210,306
4,523,454
2,602,755
Total liabilities and stockholders' equity
4,781,331
6,487,303
6,050,807
4,175,121
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash$3,475,003 Prepaid expenses andother current assets$398,765 Short-term investments$142,103 Accounts receivable$48,998 Intellectual property, net$339,016 Property & equipment, net$229,017 Right of use assets$84,415 Long-term receivables$64,014 Total current assets$4,064,869 Total non-currentassets$716,462 Total assets$4,781,331 Total liabilities andstockholders' equity$4,781,331 Total stockholders'equity$4,344,240 Total liabilities$437,091 Non-controlling interest-$393,970 Equity attributable toshareholders of lexaria$4,738,210 Total currentliabilities$383,412 Lease liabilities -non-current$53,679 Accumulated deficit-$68,496,801 Accumulated othercomprehensive loss-$46,473 Additional paid-in capital$73,256,696 Accounts payable andaccrued liabilities$350,377 Lease liability,current$33,035 Authorized 220,000,000common voting shares...$24,788

Lexaria Bioscience Corp. (LEXX)

Lexaria Bioscience Corp. (LEXX)